RevitaLash / RevitaBrow Side Effects Settlement
Filed against Athena Cosmetics · Deadline: April 20, 2026
People who used Athena Cosmetics often qualify for 41 more open settlements
- DeVry · DeVry Refunds
- Unknown · VSL#3 Probiotic $20M False Advertising Class Action Settlement
- University of Phoenix · University of Phoenix Settlement
Free to download. Answer a few questions about the brands you use to see every match.
About This Settlement
Athena Cosmetics failed to disclose potential side effects of RevitaLash and RevitaBrow products. Purchasers from Jan 1, 2017 through Dec 29, 2025 qualify. No proof of purchase required.
Filing Has Closed
The deadline to file a claim was April 20, 2026. The administrator is no longer accepting claims, and there is nothing to submit here. If you filed before the deadline, any payment comes from the administrator directly.
Check the official settlement site for distribution updates →Frequently Asked Questions
How much can I get from the Athena Cosmetics settlement?
The estimated payout is $55, ranging from $20 to $110. Actual amounts depend on the number of valid claims filed.
What is the deadline to file a claim?
The claim deadline was April 20, 2026 and it has passed. The administrator is no longer accepting claims for this settlement.
Do I need proof to file a claim?
No proof of purchase is required for this settlement. You can file a claim without documentation.
Can I still file a claim?
No. Filing for this settlement has closed and late claims are not accepted. Browse the settlements still open below — most people qualify for more than one.
Who is eligible for this settlement?
This settlement is available to eligible consumers in the United States. Check the official settlement notice for detailed eligibility criteria.
Other False Advertising Settlements
See every settlement you qualify for
Tell SettleScout which brands you use and it matches you with open settlements, estimates your payouts, and reminds you before every deadline.
Free to download. Premium plans available.